{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-AE1T4BU9/b54a1738-c61e-4f94-9499-9c28cf86fce7/HTML","dcterms:extent":"32 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-AE1T4BU9/37199af3-39b7-4709-a9da-c34586f20a2c/PDF","dcterms:extent":"95 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-AE1T4BU9/7796018b-fecb-4f8f-bf8d-c91b21674c17/TEXT","dcterms:extent":"28 KB"}],"edm:TimeSpan":{"@rdf:about":"1929-2026","edm:begin":{"@xml:lang":"en","#text":"1929"},"edm:end":{"@xml:lang":"en","#text":"2026"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:DOC-AE1T4BU9","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp"},{"@xml:lang":"sl","#text":"Zdravniški vestnik"}],"dcterms:issued":"2001","dc:creator":["Čižman, Milan","Keše, Darja","Marin, Jožica"],"dc:format":[{"@xml:lang":"sl","#text":"številka:6"},{"@xml:lang":"sl","#text":"letnik:70"},{"@xml:lang":"sl","#text":"str. 329-333"}],"dc:identifier":["ISSN:1318-0347","COBISSID:13587929","URN:URN:NBN:SI:doc-AE1T4BU9"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"dc:subject":[{"@xml:lang":"en","#text":"Antibodies, bacterial"},{"@xml:lang":"en","#text":"bacteria"},{"@xml:lang":"sl","#text":"bakterije"},{"@xml:lang":"sl","#text":"bakterijske infekcije"},{"@xml:lang":"en","#text":"Chlamydia infections"},{"@xml:lang":"en","#text":"Chlamydia pneumoniae"},{"@xml:lang":"en","#text":"Community-acquired infections"},{"@xml:lang":"en","#text":"Diagnosis"},{"@xml:lang":"sl","#text":"epidemiologija"},{"@xml:lang":"en","#text":"Epidemiology"},{"@xml:lang":"en","#text":"IgG"},{"@xml:lang":"en","#text":"Immunology"}],"dcterms:temporal":{"@rdf:resource":"1929-2026"},"dc:title":{"@xml:lang":"sl","#text":"Chlamydia pneumoniae - prevalenca protiteles pri zdravi populaciji in bolnikih z doma pridobljeno pljučnico| Chlamydia pneumoniae - the prevalence of antibodies in healthy population and patients with community acquired pneumonia|"},"dc:description":[{"@xml:lang":"sl","#text":"Background. To determinate the prevalence rates of Chlamydia pneumoniae infections in Slovenia and to evaluate the importance of C. pneumoniae infections at patients with community acquired pneumonia (CAP). Materials and methods. With the microimmunofluorescence test (micro-IF) we evaluated the presence of C pneumoniae specific antibodies in 1036 healthy subjects, in two periods of time, in 1991-93 and 1997-1998. We also tested the pair sera collected from 2118 patients with CAP between 1993-1999. Results. We demonstrated that C. pneumoniae infections are common in our population, as wedetected IgG antibodies in 43.1% of healthy population. The prevalence rate of C. pneumaniae infectians statistically significant increased in two periodsof time. Acute C. pneumoniae infections were proved in 15.9% of all patients with CAP. Conclusions. C. pneumoniae is important respiratory pathogen also in aur community. The infections are more common in older patients. Because C. pneumoniae like other Chlamydia species has tendency to cause chronic disease, it is reasonable to diagnose this bacterium in respiratory patients. It is also recommended to test canvalescent sera at serologic laboratory diagnosis"},{"@xml:lang":"sl","#text":"Izhodišča. Da bi ugotovili razširjenost okužb z bakterijo Chlamydia pneumoniaev Sloveniji in ovrednotili njen pomen pri bolnikih z doma pridobljeno pljučnico. Materiali in metode. V serumih 1038 asimptomatskih osebsmo ugotavljali protitelesni imunski odziv proti C. pneumoniae z metodo mikroimunofluorescence, in sicer v obdobju 1991-93 in v letih 1997-98. Prav tako smo preiskali parne serume 2118 bolnikov z doma pridobljeno pljučnico, zbrane v obdobju 1993-1999. Rezultati. Ugotovili smo, da so tudi pri nas okužbe s C. pneumoniae razmeroma pogoste, saj smo protitelesa IgG dokazali pri43,1% pregledane populacije. Prekuženost prebivalcev v dveh ločenih obdobjih se je statistično značilno povečala. Akutno okužbo s C. pneumoniae smo dokazali pri 15,9% bolnikov z doma pridobljeno pljučnico. Zaključki. C. pneumoniae je pomemben povzročitelj bolezni dihal tudi v našem prostoru. Okužbe so pogostejše pri odraslih bolnikih. Glede na to, da C. pneumoniae izraža tendenco po povzročanju kroničnih okužb, je smiselno iskanje tega povzročitelja pri bolnikih. Prav tako moramo ob uporabi serološkega testa mikro-lF vedno pregledati tudi serum, odvzet v konvalescentni stopnji bolezni"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:DOC-AE1T4BU9","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:DOC-AE1T4BU9"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:DOC-AE1T4BU9/37199af3-39b7-4709-a9da-c34586f20a2c/PDF"},"edm:rights":{"@rdf:resource":"http://creativecommons.org/licenses/by-nc/4.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:DOC-AE1T4BU9/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:DOC-AE1T4BU9"}}}}